U.K. coronavirus strain no deadlier among hospitalized patients, study suggests


The B.1.1.7 coronavirus variant first discovered in Britain spreads more easily that older strains, sending more people to the hospital, but it doesn't lead to more severe cases or higher rates of death once patients are hospitalized, a study published Monday in the journal The Lance Infectious Disease found.
"If you need hospitalization, you're not worse with this variant compared to the previous virus strain," said Eleni Nastouli, senior author of the paper and a clinical virologist and pediatrician at University College London. "Of course, if you're requiring hospital admission for COVID, that is a worry," she conceded. "But it's not more than the previous strain."
It has been clear for months that the B.1.1.7 variant is more contagious than earlier ones, and other researchers have found that it is deadlier overall. One of those researchers, Nicholas Davies at the London School of Hygiene and Tropical Medicine, told The Wall Street Journal the new study doesn't contradict the other ones. The current evidence points to the U.K. strain being "more likely to land you in the hospital," he said, but no likelier to have a bad outcome once you are hospitalized.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The study was conducted last fall, before a B.1.1.7-fueled surge overwhelmed British hospitals.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The party bringing Trump-style populism to Japan
Under The Radar Far-right party is ‘Rise of Sanseito is ‘shattering’ the belief that Japan is ‘immune’ to populism’ the belief that Japan is ‘immune’ to populism
-
Southern barbecue: This year’s top three
Feature A weekend-only restaurant, a 90-year-old pitmaster, and more
-
Film reviews: Anemone and The Smashing Machine
Feature A recluse receives an unwelcome guest and a pioneering UFC fighter battles addiction
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials